Investor desk
Watch for partnership announcements between health systems and specialty pharma; PBM-adjacent vendors (data, AI, hub services) often preview enterprise deals here.
← Back to Events
Tier 1 Global Networking: High CARDIOLOGY CONCLUDED
THMA Pharmacy Growth — 2026 — Carlsbad, USA
Carlsbad, CA . The Health Management Academy's (THMA) Pharmacy Growth Collaborative brings health system pharmacy leaders and select industry executives .
400+ Attendees
6 Presentations
4 Companies
4 Drugs
Presentation data updated Jun 10, 2026, 5:33 AM UTC
Why This Event Matters
The Health Management Academy's (THMA) Pharmacy Growth Collaborative brings health system pharmacy leaders and select industry executives .
Industry impact
Carlsbad, CA .
Market implications
Expect signals on PBM–provider alignment, biosimilar tendering, and ambulatory margin recovery as systems negotiate manufacturer contracts.
Regulatory implications
FDA real-world evidence pilots and 340B policy uncertainty shape how pharmacy leaders justify evidence-generation and access investments.
Investor implications
Watch for partnership announcements between health systems and specialty pharma; PBM-adjacent vendors (data, AI, hub services) often preview enterprise deals here.
Competitive implications
Competitive positioning among top cardiology players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.
Event Significance
Tier-1 industry catalyst
47 /100 composite
THMA Pharmacy Growth is a targeted cardiology forum where specialty pipeline readouts and BD conversations drive near-term positioning decisions. Primary driver: speaker calibre and KOL density.
- Media coverage 10/20
Moderate coverage; Nova editorial will prioritize confirmed data releases.
- Speaker quality 15/20
Plenary and late-breaker slots attract global KOLs — high signal for clinical and regulatory teams.
- Pipeline relevance 1/20
Early science or services-focused — lower near-term PDUFA linkage.
- Historical influence 13/20
Some historical catalysts; compare readouts against last cycle.
- Company participation 8/20
Meaningful sponsor footprint; BD teams can pre-book partnering slots.
Nova Pharma Intelligence · Analyst desk
Key Takeaways
- AstraZeneca carries 1 tracked presentations — map against peer readouts at THMA Pharmacy Growth.
- Arcturus Therapeutics carries 1 tracked presentations — map against peer readouts at THMA Pharmacy Growth.
- Watch for partnership announcements between health systems and specialty pharma; PBM-adjacent vendors (data, AI, hub services) often preview enterprise deals here.
- FDA real-world evidence pilots and 340B policy uncertainty shape how pharmacy leaders justify evidence-generation and access investments.
- tixagevimab (AstraZeneca) — 1 data points on the schedule.
- azacitidine (Bristol Myers Squibb) — 1 data points on the schedule.
Timeline & Milestones
- Pre-event intelligence Complete
6 presentations tracked — Key Data and Companies hubs live.
- Conference opens Jun 3, 2026 Complete
Live readouts, late-breakers, and partnership announcements.
- Live coverage window Complete
1 Nova articles linked — see Coverage & Analysis.
- Conference closes Jun 5, 2026 Complete
Post-event recap, competitive takeaways, and trial updates.
Pharma executives Market access teams BD professionals Investors & analysts
Executive Summary
C-level briefThe Health Management Academy's (THMA) Pharmacy Growth Collaborative brings health system pharmacy leaders and select industry executives .
Primary audience: Pharma executives · Market access teams · BD professionals · Investors & analysts
Analyst Watch
Regulatory affairs
FDA real-world evidence pilots and 340B policy uncertainty shape how pharmacy leaders justify evidence-generation and access investments.
Competitive intelligence
Competitive positioning among top cardiology players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.
vs. Prior Editions
| Edition | Presentations | Companies |
|---|---|---|
| THMA Pharmacy Growth (current) | 6 | 4 |
| THMA CPE Circle (2026) | 1 | 0 |
| THMA Oncology Forum (2026) | 4 | 0 |
Most Anticipated Presentations
Full data hub → PLENARY Jun 3
Topline Results from the Phase 3 PEAK Trial: Tixagevimab/Cilgavimab for Pre-Exposure Prophylaxis of COVID-19
ORAL Jun 3
Phase 3 Results of Oral GLP-1 Receptor Agonist for Obesity
POSTER Jun 4
A Phase 3 Study of Oral Azacitidine (CC-486) Versus Placebo in Patients with Acute Myeloid Leukemia in First Remission
ORAL Jun 5
Updated Results from Phase 1/2 Trial of TCR-T cell therapy in solid tumors
ORAL Jun 5
Arcturus Therapeutics: Phase 3 Study of ARCT-810 (mRNA Therapeutic) for Ornithine Transcarbamylase Deficiency
POSTER Jun 4
A Randomized Trial of Weekly Semaglutide in Overweight Adults with Type 2 Diabetes
Competitive Landscape
Company map →Competitive positioning among top cardiology players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.
Companies to Watch
All companies →Drug Pipelines to Watch
Pipeline data →Coverage & Analysis
1 articlesRelated News & Research
Research hub →Event Intelligence Summary
Standalone summaries for THMA Pharmacy Growth — optimized for research and AI retrieval.
Executive Summary
The Health Management Academy's (THMA) Pharmacy Growth Collaborative brings health system pharmacy leaders and select industry executives .
Analyst View
Carlsbad, CA .
Investor View
Watch for partnership announcements between health systems and specialty pharma; PBM-adjacent vendors (data, AI, hub services) often preview enterprise deals here.
BD View
BD teams should prioritize networking with presenting companies and services vendors at THMA Pharmacy Growth, focusing on cardiology partnership and licensing opportunities.
Key Facts
- Event
- THMA Pharmacy Growth
- Focus
- cardiology
- Region
- US Americas
- Attendance
- 400+
Ask Nova AI
AI-assisted answers grounded in NovaPharmaNews intelligence
Answers use retrieved site intelligence plus AI synthesis. Verify critical decisions with primary sources.
Frequently Asked Questions
What is THMA Pharmacy Growth?
THMA Pharmacy Growth is a cardiology industry conference bringing together executives, clinical leaders, and investors to discuss pipeline, regulatory, and commercial strategy.
Who attends THMA Pharmacy Growth?
Typical attendees include pharma executives, BD teams, investors, regulatory affairs professionals, and clinical operations leaders focused on cardiology.
Why is THMA Pharmacy Growth important?
THMA Pharmacy Growth influences partnership timing, pipeline prioritization, and policy debates that affect cardiology markets for the next 12–18 months.
When is THMA Pharmacy Growth?
THMA Pharmacy Growth takes place on the scheduled dates.
Where is THMA Pharmacy Growth held?
THMA Pharmacy Growth is held in the listed venue.
How many attendees does THMA Pharmacy Growth attract?
THMA Pharmacy Growth typically draws 400+ attendees from across the cardiology ecosystem.
What companies participate at THMA Pharmacy Growth?
4+ companies present data or participate in programming at THMA Pharmacy Growth, spanning large pharma, biotech, and services vendors.
What should investors watch at THMA Pharmacy Growth?
Investors should track partnership announcements, pipeline readouts, M&A signals, and management commentary on cardiology catalysts during and after THMA Pharmacy Growth.
What BD opportunities exist at THMA Pharmacy Growth?
BD teams use THMA Pharmacy Growth for licensing discussions, co-development talks, and vendor selection across cardiology — especially in networking sessions and satellite meetings.
How does THMA Pharmacy Growth compare with other pharma conferences?
THMA Pharmacy Growth is a tier-1 global congress for cardiology — compare speaker quality, company participation, and historical deal flow with peer events in the same therapeutic or commercial vertical.
How do I get NovaPharmaNews coverage of THMA Pharmacy Growth?
NovaPharmaNews publishes pre-event briefs, live coverage, and post-event analysis for THMA Pharmacy Growth. Subscribe to event alerts on this page for breaking updates.